Abrace Esperança
Abrace Esperança is a Brazilian nonprofit association, judicially authorized since 2017 to cultivate Cannabis sativa and produce oils, ointments, and gummies for its members nationwide. It serves patients with chronic conditions via a prescriber-referred membership model, with reduced pricing and a social exemption program for low-income members.
- Company typePrivate
- Founded2014
- HeadquartersJoão Pessoa, Brazil
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Abrace Esperança does
Abrace Esperança (legal name: Associação Brasileira de Apoio Cannabis Esperança) is a Brazilian nonprofit association headquartered in João Pessoa, Paraíba, founded in 2014 to provide patient access to Cannabis-based medicinal treatments. The organization holds judicial authorization since 2017 to cultivate Cannabis sativa and produce derivative products — oils, ointments, gummies, and flowers for vaporization — in its own ANVISA-standard laboratory staffed by pharmacists and chemists. It complements its core pharmaceutical activity with the Museu Brasileiro da Cannabis (Brazil's first Cannabis museum), a weekly podcast (Gotas da Esperança), and educational research collaborations.
The association's revenue model combines annual membership fees with product sales at reduced prices to registered members, supplemented by donations. Members must present a medical prescription and CID diagnostic report to enroll; a national prescriber referral network of more than 500 doctors across all 27 Brazilian states feeds new members into the association. A social exemption program (Programa de Isenção) waives annual fees and product costs for low-income members — in 2023, 1,289 annual fee exemptions and 1,292 product cost exemptions were granted — making the association as much a public-health access platform as a product supplier.
Commercial distribution operates through Abrace's own e-commerce storefront (lojaabraceesperanca.com) with national logistics delivery and local pickup at the João Pessoa headquarters. The organization also serves veterinary patients through Cannabis formulations based on the mammalian endocannabinoid system. In 2026, Abrace launched Cannabis gummies and received international recognition at CannaPortugal, while Brazil's ANVISA approved new regulations permitting export of cannabis-derived products — opening potential international channels for the association's in-house production capacity.
Abrace Esperança firmographics
Firmographics- Name
- Abrace Esperança
- Legal name
- Associação Brasileira de Apoio Cannabis Esperança
- Website
- https://abraceesperanca.org.br
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Abrace Esperança is a Brazilian nonprofit association, judicially authorized since 2017 to cultivate Cannabis sativa and produce oils, ointments, and gummies for its members nationwide. It serves patients with chronic conditions via a prescriber-referred membership model, with reduced pricing and a social exemption program for low-income members.
- Ownership category
- akta.pro rank
Abrace Esperança industry classification
Industry- Product category
- Medicinal Cannabis Treatment
- NAICS
- Business Associations (813910)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
Keywords
Where Abrace Esperança is headquartered
LocationHeadquarters
- HQ city
- João Pessoa
- HQ country
- Brazil
- HQ region
- Latin America
Offices2 records
Markets served
Abrace Esperança business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- Annual Membership Fees: Members pay an annual association fee to access Cannabis-derived products. The association also maintains an exemption (Isenção) program that grants full or partial fee waivers for low-income members. In 2023, 1,289 annual fee exemptions were granted, and 1,292 members received full or partial exemptions for product acquisition.
- Product Sales (Oils, Ointments, Gummies): Sale of Cannabis-derived products (oils, ointments, gummies) to members at reduced prices. Products are sold through the online store and at the local headquarters. Members access products in compliance with the association's catalogue and applicable pricing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Standard annual membership fee for patients |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Abrace Esperança product offering
Product offeringCore offering
Abrace Esperança is a nonprofit association headquartered in João Pessoa, Paraíba, Brazil, that has been judicially authorized since 2017 to cultivate Cannabis sativa and supply derivative products to its registered members. It produces and distributes Cannabis-derived oils, ointments, gummies, and flowers for vaporization exclusively to members holding a valid medical prescription and CID diagnostic report. The association also runs a social exemption (Isenção) program granting full or partial waivers of membership fees and product costs to low-income members.
Product overview
Abrace Esperança is a non-profit association headquartered in João Pessoa, Paraíba, authorized since 2017 by Brazilian courts to cultivate Cannabis and supply derivatives to its members. The organization's product portfolio centers on Cannabis-derived medicinal products including Óleo Esperança (the flagship cannabis oil), medicinal gummies (launched 2026), topical ointments, and medicinal cannabis flowers for vaporization. These products are distributed exclusively to registered members with valid medical prescriptions. The association complements its product offerings with social programs such as the Isenção program (social exemptions for low-income members) and Abrace+ membership benefits (partner discounts). Educational initiatives include the Podcast Gotas da Esperança and the Museu Brasileiro da Cannabis (Brazilian Cannabis Museum). Members access services through the Abrace Academy online portal.
Differentiator
Problem solved
Functional benefit
Brands
- Óleo Esperança: The organization's flagship Cannabis medicinal oil product.
- Abrace Mais (Abrace+)
- Gotas da Esperança
- Museu Brasileiro da Cannabis
Products and services
- Óleo Esperança (Cannabis Medicinal Oil) Flagship Cannabis sativa-derived medicinal oil produced through the association's authorized in-house cultivation. Distributed exclusively to members with a valid medical prescription and CID report for treatment of epilepsy, autism, chronic pain, fibromyalgia, Alzheimer's, and other conditions.
- Gominhas de Cannabis Medicinal (Cannabis Gummies) Cannabis gummies containing CBD, THC, and combined cannabinoid formulations for medicinal use, distributed to association members with medical prescription.
- Pomadas de Cannabis (Cannabis Ointments) Topical ointments derived from Cannabis sativa provided to members as part of the product catalog for transdermal therapeutic applications.
- Flores de Cannabis Medicinal (Medicinal Cannabis Flowers)
Quantifiable outcome
- 1,292 members received full or partial product cost exemptions in 2023
- +3 more outcomes
Companies that use Abrace Esperança
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
Abrace Esperança technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Abrace Esperança partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CannaPortugalcoreAbrace Esperança was recognized at the CannaPortugal 2026 event, one of the most important international gatherings for cannabis medicinal, innovation, research, and public policy. The recognition underscores Abrace's role as an international reference in health, scientific research, and social inclusion.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
Abrace Esperança competitors and assessment
Company assessmentOthers
Broad incumbents
- MedMen: US cannabis retailer with dispensary operations and branded product lines targeting medical and adult-use patients. Comparable to Abrace in retail-format medical-cannabis patient experience, though operating in a more permissive US regulatory environment.
- Trulieve Cannabis: US-listed medical-cannabis-focused operator with owned cultivation, processing, and patient-facing dispensary infrastructure. Comparable to Abrace for its cultivation-plus-direct-patient distribution model and emphasis on patient outcomes rather than purely adult-use markets.
- Cronos Group: Global cannabis holding company with operations across cultivation, product manufacturing, and international distribution including medical markets. Relevant as a broad-incumbent comparable for Abrace's longer-term international ambitions signaled by its CannaPortugal 2026 recognition.
- Organigram Holdings: Canadian licensed cannabis producer with medical and adult-use product lines including oils and edible formats. Comparable to Abrace in its cultivation-plus-derivative-product strategy (oils, gummies, extracts), particularly relevant as Abrace scales its gummy line launched in 2026.
- Curaleaf Holdings: US-listed multi-state cannabis operator with dispensary, cultivation, and product manufacturing, including a focus on medical-cannabis patient access. Comparable to Abrace in its patient-centric medical cannabis distribution and cultivation-to-product vertical integration.
- Tilray Brands: Global medical and adult-use cannabis producer with pharmaceutical-grade cultivation and GMP-certified manufacturing across multiple jurisdictions. Comparable to Abrace in its cultivation-to-patient pipeline and regulatory-driven go-to-market, but at global scale and for-profit.
- Aurora Cannabis: Canadian-licensed medical cannabis producer with large-scale cultivation, oil/extract production, and international distribution. Comparable in medicinal cannabis product mix (oils, softgels, derivatives) and the regulatory-license-driven go-to-market that Abrace is building toward with its ANVISA-standard lab.
Emerging players
- Khiron Life Sciences: Latin America-focused medical cannabis company with operations in Colombia, Brazil, and other LATAM markets, distributing cannabis-derived medicines through pharmacy and prescription channels. Most regionally comparable peer to Abrace given overlapping LATAM footprint and Brazilian market ambitions.
Direct peers
- APEPI: Associação de Pesquisa e Apoio à Cannabis Medicinal is a Rio de Janeiro-based nonprofit cannabis association operating under a similar judicial-authorization model, cultivating Cannabis for medicinal distribution to registered members. Directly comparable to Abrace in nonprofit structure, member-gated distribution, and Brazilian regulatory posture.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Abrace Esperança social profiles
Digital presenceAbrace Esperança financial estimates
Financial estimateRevenue estimate
Valuation estimate
Abrace Esperança leadership team
Management profileNumber of profiles
Profiles2 records
Abrace Esperança funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Abrace Esperança M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Abrace Esperança
What does Abrace Esperança do?
Abrace Esperança is a nonprofit association headquartered in João Pessoa, Paraíba, Brazil, that has been judicially authorized since 2017 to cultivate Cannabis sativa and supply derivative products to its registered members. It produces and distributes Cannabis-derived oils, ointments, gummies, and flowers for vaporization exclusively to members holding a valid medical prescription and CID diagnostic report. The association also runs a social exemption (Isenção) program granting full or partial waivers of membership fees and product costs to low-income members.
Is Abrace Esperança a public or private company?
Abrace Esperança is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Abrace Esperança founded?
Abrace Esperança was founded in 2014. It employs 11 to 50 people.
Where is Abrace Esperança based?
Abrace Esperança is headquartered in João Pessoa, Brazil, in the Latin America region.
How does Abrace Esperança make money?
Two revenue lines are on record. Annual Membership Fees are the primary driver. The others are product Sales (Oils, Ointments, Gummies).
Who are Abrace Esperança's main competitors?
Canopy Growth is listed as an others. Broad incumbents are MedMen, Trulieve Cannabis, Cronos Group, Organigram Holdings, Curaleaf Holdings, Tilray Brands and Aurora Cannabis. Khiron Life Sciences is listed as an emerging player. APEPI is listed as a direct peer.
Does Abrace Esperança have an API?
No public API is recorded for Abrace Esperança.
What industry is Abrace Esperança in?
Abrace Esperança's product category is Medicinal Cannabis Treatment. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services). Its NAICS code is 813910 and its SIC code is 2833.